Bernstein Harold

Track

Insider profile

Bernstein Harold's trades of Maze Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-07-01
PlS Planned sale
66,603 -16.2%
151.85
US$2,321,348 		66,603 -16.2% 151.85 US$2,321,348
2026-07-02 2026-07-01
PlS Planned sale
73,943 +33.8%
361.41
US$4,646,876 		73,943 +33.8% 361.41 US$4,646,876
2026-07-01 2026-07-01
PrS Proposed sale
67,242
172.12
US$2,813,330 		67,242 172.12 US$2,813,330
2026-06-03 2026-06-01
PlS Planned sale
1,600 -100.0%
26.36
US$42,172 		1,600 -100.0% 26.36 US$42,172
2026-06-03 2026-06-01
PlS Planned sale
13,253 -89.2%
25.57
US$338,940 		13,253 -89.2% 25.57 US$338,940
2026-05-18 2026-05-14
PlS Planned sale
15,000 -100.0%
26.22
US$393,354 		15,000 -100.0% 26.22 US$393,354
2026-04-02 2026-04-01
PlS Planned sale
300 -100.0%
31.07
US$9,320 		300 -100.0% 31.07 US$9,320
2026-04-02 2026-04-01
PlS Planned sale
3,348 -91.8%
30.06
US$100,636 		3,348 -91.8% 30.06 US$100,636
2026-04-02 2026-04-01
PlS Planned sale
11,352 -75.7%
29.24
US$331,948 		11,352 -75.7% 29.24 US$331,948
2026-03-20 2026-03-20
PlS Planned sale
5,044 -100.0%
50.02
US$252,294 		5,044 -100.0% 50.02 US$252,294
2026-03-20 2026-03-20
PlS Planned sale
3,795 -42.9%
49.32
US$187,169 		3,795 -42.9% 49.32 US$187,169
2026-03-20 2026-03-20
PlS Planned sale
6,161 -41.1%
48.20
US$296,977 		6,161 -41.1% 48.20 US$296,977
2026-03-12 2026-03-10
PlS Planned sale
348 -100.0%
51.02
US$17,753 		348 -100.0% 51.02 US$17,753
2026-03-12 2026-03-10
PlS Planned sale
29,652 -98.8%
50.45
US$1,495,807 		29,652 -98.8% 50.45 US$1,495,807
2026-03-10 2026-03-10
PrS Proposed sale
74,853
45.06
US$3,372,876 		74,853 45.06 US$3,372,876
2026-02-04 2026-02-02
PlS Planned sale
100 -100.0%
47.23
US$4,723 		100 -100.0% 47.23 US$4,723
2026-02-04 2026-02-02
PlS Planned sale
5,936 -98.3%
46.37
US$275,271 		5,936 -98.3% 46.37 US$275,271
2026-02-04 2026-02-02
PlS Planned sale
8,364 -58.1%
45.89
US$383,816 		8,364 -58.1% 45.89 US$383,816
2026-02-04 2026-02-02
PlS Planned sale
600 -4.0%
44.21
US$26,523 		600 -4.0% 44.21 US$26,523
2026-02-04 2026-02-02
PlS Planned sale
100 -100.0%
47.23
US$4,723 		100 -100.0% 47.23 US$4,723
2026-02-04 2026-02-02
PlS Planned sale
5,936 -98.3%
46.37
US$275,271 		5,936 -98.3% 46.37 US$275,271
2026-02-04 2026-02-02
PlS Planned sale
8,364 -58.1%
45.89
US$383,816 		8,364 -58.1% 45.89 US$383,816
2026-02-04 2026-02-02
PlS Planned sale
600 -4.0%
44.21
US$26,523 		600 -4.0% 44.21 US$26,523
2026-01-09 2026-01-07
PlS Planned sale
25,156 -100.0%
40.20
US$1,011,299 		25,156 -100.0% 40.20 US$1,011,299
2026-01-06 2026-01-05
PlS Planned sale
412 -100.0%
40.00
US$16,480 		412 -100.0% 40.00 US$16,480
2026-01-06 2026-01-02
PlS Planned sale
4,432 -100.0%
40.43
US$179,188 		4,432 -100.0% 40.43 US$179,188
2025-12-31 2025-12-29
PlS Planned sale
17,200 -100.0%
40.93
US$703,931 		17,200 -100.0% 40.93 US$703,931
2025-12-31 2025-12-29
PlS Planned sale
27,800 -61.8%
40.34
US$1,121,424 		27,800 -61.8% 40.34 US$1,121,424
2025-12-29 2025-12-29
PrS Proposed sale
105,000
42.10
US$4,420,500 		105,000 42.10 US$4,420,500